Table of Contents: Global Health Diplomacy Collection


Image Credit:
Issue Image

In April 2010 PLoS Medicine launched a six-part series on global health diplomacy. In the introductory article, Harley Feldbaum and Joshua Michaud consider the important interplay between foreign policy and global health interests and argue that despite recent suggestions to the contrary, foreign policy interests are of primary importance to global health diplomacy. Kelly Lee and colleagues discuss Brazil's growing influence in international relations and global health, and its use of "soft power" in the negotiation of the Framework Convention on Tobacco Control. Lai-Ha Chan and colleagues examine China's growing interest in public health, at both national and international levels, and examine whether SARS was a watershed for China in its engagement in global health diplomacy. David Fidler provides a case study of the negotiations and controversies surrounding highly pathogenic avian influenza A (H5N1) and pandemic 2009 influenza A (H1N1) and discusses whether these might limit equitable access to influenza vaccines. The PLoS Medicine series on global health diplomacy concludes with two Perspectives from high level diplomats involved in global health negotiations. Sigrun Modegal and Benedikte Alveberg bring an international and United Nations perspective to the question of whether foreign policy can make a difference to health, and Kerri-Ann Jones provides a perspective from the United States State Department.

Image Credit: Tom Hilton at


Can Foreign Policy Make a Difference to Health?

Sigrun M√łgedal, Benedikte Louise Alveberg

Policy Forums